Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2010 | 12-2009 | 12-2008 | 03-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9 | -22 | -16 | N/A | -5 |
| Accounts payable and accrued liabilities | 2 | -1 | 2 | N/A | N/A |
| Other Working Capital | 2 | -1 | 2 | N/A | N/A |
| Other Operating Activity | -2 | 1 | -2 | 0 | 0 |
| Operating Cash Flow | $-7 | $-23 | $-14 | $N/A | $-5 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -1 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-1 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | 1 | N/A | N/A |
| Common Stock Issued | 8 | 2 | 37 | N/A | N/A |
| Financing Cash Flow | $8 | $2 | $37 | $N/A | $N/A |
| Beginning Cash Position | 1 | 22 | 0 | N/A | 5 |
| End Cash Position | 2 | 1 | 22 | N/A | 0 |
| Net Cash Flow | $1 | $-21 | $22 | $N/A | $-5 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7 | -23 | -14 | N/A | -5 |
| Capital Expenditure | N/A | N/A | -1 | N/A | N/A |
| Free Cash Flow | -7 | -23 | -16 | 0 | -5 |